|
C1ORF103 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.40530000000084E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.50760000000272E-05 |
| Normal-vs-Stage2 |
7.391600E-02 |
| Normal-vs-Stage3 |
2.604700E-04 |
| Normal-vs-Stage4 |
2.790100E-04 |
| Stage1-vs-Stage2 |
3.040000E-01 |
| Stage1-vs-Stage3 |
6.820200E-01 |
| Stage1-vs-Stage4 |
2.493800E-01 |
| Stage2-vs-Stage3 |
2.077000E-01 |
| Stage2-vs-Stage4 |
1.133000E-01 |
| Stage3-vs-Stage4 |
4.671600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.40670000000365E-05 |
| Normal-vs-AfricanAmerican |
6.456100E-03 |
| Normal-vs-Asian |
6.154200E-04 |
| Caucasian-vs-AfricanAmerican |
8.565600E-01 |
| Caucasian-vs-Asian |
5.956200E-01 |
| AfricanAmerican-vs-Asian |
8.455600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.959900E-04 |
| Normal-vs-Female |
1.164860E-04 |
| Male-vs-Female |
6.844400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.231400E-04 |
| Normal-vs-Age(41-60Yrs) |
7.60710000000664E-05 |
| Normal-vs-Age(61-80Yrs) |
4.436700E-04 |
| Normal-vs-Age(81-100Yrs) |
3.648100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.572600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.349800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.614400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.789800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.806000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.008200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.722000E-01 |
| Classical-VS-Follicular |
9.111400E-01 |
| Classical-VS-Other |
6.845600E-01 |
| Classical-VS-Normal |
2.551700E-04 |
| Tall-VS-Follicular |
4.267200E-01 |
| Tall-VS-Other |
3.883000E-01 |
| Tall-VS-Normal |
1.460310E-03 |
| Follicular-VS-Other |
7.136000E-01 |
| Follicular-VS-Normal |
4.663900E-03 |
| Other-VS-Normal |
3.074800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.212600E-04 |
| Normal-vs-N1 |
4.820200E-04 |
| N0-vs-N1 |
4.398600E-01 |
|
|
